Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2022-10-19 00:00:00 ET · period of report 2022-10-17 · accession 0001415889-22-010716 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-10-19 | 2022-10-17+ | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $30.86 | +6,901 | 61.1K | +13% | +$213.0K |
| DM | 2022-10-19 | 2022-10-17+ | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $55.00 | -6,901 | 61.1K | -10% | -$379.6K |
| DM | 2022-10-19 | 2022-10-17+ | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $30.86 | -6,901 | 68.6K | -9% | -$213.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-17 | M | A | 6,402 | $30.86 | 67,512 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-17 | S | D | 200 | $55.00 | 61,110 | D | — | — | |
| 3 | Common | Common Stock | 2022-10-18 | M | A | 289 | $30.86 | 61,399 | D | — | — | |
| 4 | Common | Common Stock | 2022-10-18 | S | D | 10 | $55.45 | 61,110 | D | — | — | |
| 5 | Common | Common Stock | 2022-10-17 | M | A | 200 | $30.86 | 61,310 | D | — | — | |
| 6 | Common | Common Stock | 2022-10-18 | M | A | 10 | $30.86 | 61,120 | D | — | — | |
| 7 | Common | Common Stock | 2022-10-17 | S | D | 6,402 | $55.00 | 61,110 | D | — | — | |
| 8 | Common | Common Stock | 2022-10-18 | S | D | 289 | $55.04 | 61,110 | D | — | — | (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.00 to $55.57 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 9 | Derivative | Stock Option (Right to Buy) | 2022-10-18 | M | D | 289 | $30.86 | 61,923 | D | $30.86 · — to 2026-01-03 | 289 Common Stock | (F3) Currently exercisable. |
| 10 | Derivative | Stock Option (Right to Buy) | 2022-10-18 | M | D | 10 | $30.86 | 62,212 | D | $30.86 · — to 2026-01-03 | 10 Common Stock | (F3) Currently exercisable. |
| 11 | Derivative | Stock Option (Right to Buy) | 2022-10-17 | M | D | 6,402 | $30.86 | 62,222 | D | $30.86 · — to 2026-01-03 | 6,402 Common Stock | (F3) Currently exercisable. |
| 12 | Derivative | Stock Option (Right to Buy) | 2022-10-17 | M | D | 200 | $30.86 | 68,624 | D | $30.86 · — to 2026-01-03 | 200 Common Stock | (F3) Currently exercisable. |